The Impacts of Oral Anticoagulants on Clinical Outcomes in Patients with Atrial Fibrillation Across Five Stages of Renal Function
Liao, J.-N.; Chan, Y.-H.; Lee, H.-F.; Yeh, Y.-H.; Chang, S.-H.; Chen, S.-A.; Chao, T.-F.
Show abstract
BackgroundTo analyze the impact of using different renal function equations and stroke prevention strategy in atrial fibrillation (AF) across all chronic kidney disease (CKD) stages. MethodsWe used the Cockcroft-Gault (CG), Modified Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations to classify 39,217 patients into stage 1 to 5 CKD during July 1st, 2001, and September 30st, 2018. The endpoint is a composite outcome including ischemic stroke or major bleeding or mortality. ResultsMore patients belonged to stage 1 and 2 CKD using the MDRD and CKD-EPI equations. In subgroups of patients with eGFR-MDRD or eGFR-CKD-EPI [≥] 60 mL/min, a 17-18% increase of event was observed in patients with eGFR-CG < 60 mL/min compared to those [≥] 60 mL/min. Compared to no oral anticoagulant (OAC), OAC use was associated with a significantly lower risk of event across stage 1 to 4 CKD but not in stage 5 CKD. Both warfarin and NOACs exhibited better outcome compared to no OAC across stage 1 to 4 CKD while NOACs was associated with more risk reduction compared to warfarin. Among patients on OACs, there was a trend toward better outcome with NOAC than warfarin across stage 2-4 CKD but not in stage 1 and 5 CKD. ConclusionsOAC should be used in stage 1 to 4 CKD with NOAC exhibiting the trend of better outcome through stage 2 to 4 CKD than warfarin. For stage 5 CKD, optimal strategy remains undetermined. Clinical PerspectiveO_LIWhat Is New? The stages of renal function of AF patients varied significantly with different renal equations, and tthe CG equation remained effective in differentiating clnical outcomes for patients with eGFR-MDRD [≥] 60 mL/min or eGFR-CKD-EPI [≥] 60 mL/min C_LIO_LIWhat Are the Clinical Implications? OAC should be used in stage 1 to 4 CKD with NOAC exhibiting the trend of better outcome through stage 2 to 4 CKD than warfarin. C_LI
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clinical Outcomes, Management, Healthcare Resource Utilization, and Cost According to the CHA 2 DS 2 -VASc Scores in Asian Patients with Nonvalvular Atrial Fibrillation 96%
- Utility of the CHADS-P 2 A 2 RC score for estimating net adverse clinical events in chronic coronary syndrome patients without atrial fibrillation: insights from the CLIDAS-PCI 95%
- Temporal Variations in Ischemic and Bleeding Event Risks after Acute Coronary Syndrome during Dual Antiplatelet Therapy 95%
Similar papers in this journal
- Age-stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in Japan 94%
- Smartwatch Facilitated Remote Health Care for Patients Undergoing Transcatheter Aortic Valve Replacement Amid COVID-19 Pandemic 94%
- Surgical strategy for atrial functional mitral regurgitation with atrial fibrillation 94%
Similar papers in this journal
- Direct Oral Anticoagulants Affect Activated Clotting Time During and Bleeding Events After Percutaneous Coronary Intervention 96%
- Ticagrelor vs Clopidogrel: the Impact of Platelet Inhibition on Cerebrovascular Microembolic Events during TAVR 94%
- Sodium-glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome with Diabetes Mellitus 92%
Similar papers in this journal
- Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation 94%
- Effects of low versus high inspired oxygen fraction on myocardial injury after transcatheter aortic valve implantation: A randomized clinical trial 94%
- Association between kidney measurements and cognitive performance in patients with ischemic stroke 94%
Similar papers in this journal
- Differences in coagulation responses to vascular injury between uninterrupted dabigatran and apixaban - a clinical prospective randomized study 95%
- Procedural Volume and Outcomes with Atrial Fibrillation Ablation: A Report from the NCDR AFib Ablation Registry 95%
- Impact of transseptal puncture location on the fossa ovalis on first-pass pulmonary vein isolation 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.